SCHEMBL7635759

SCHEMBL7635759

CCOC(=O)C(C)OC(=O)[C@@H]1CCC(=O)N1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.47
CNR1 P21554 1/20 0.43
DAGLA Q9Y4D2 1/20 0.43
GAA P10253 1/20 0.42
TSHR P16473 1/20 0.39
POLB P06746 1/20 0.37
HCRTR2 O43614 1/20 0.36
CYP2D6 P10635 1/20 0.35
KDM4E B2RXH2 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ALOX12 P18054 1/20 0.33
ALDH1A1 P00352 2/20 0.33
HSD17B10 Q99714 2/20 0.33
ALOX15 P16050 1/20 0.33
HPGD P15428 1/20 0.32
ACACB O00763 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8761598 0.89 CNR1 (0.44) LMNACNR1DAGLAGAATSHR
SCHEMBL8749217 0.85 LMNA (0.43) LMNACNR1DAGLAGAATSHR
SCHEMBL8762023 0.85 LMNA (0.44) LMNACNR1DAGLAGAATSHR
SCHEMBL8748849 0.85 LMNA (0.44) LMNACNR1DAGLAGAATSHR
SCHEMBL8748821 0.84 LMNA (0.46) LMNACNR1DAGLAGAATSHR
SCHEMBL8761471 0.84 LMNA (0.46) LMNACNR1DAGLAGAATSHR
SCHEMBL8749016 0.84 CNR1 (0.51) LMNACNR1DAGLAGAATSHR
SCHEMBL8762005 0.84 CNR1 (0.51) LMNACNR1DAGLAGAATSHR
Isopropyl Alcohol SCHEMBL28077462 0.84 LMNA (0.53) LMNACNR1DAGLAGAATSHR
SCHEMBL815103 0.83 LMNA (0.58) LMNACNR1DAGLAGAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0342056-B1 Cosmetic composition UNILEVER PLC (GB) 1994-08-17 EP claimed
EP-0277428-B1 Cosmetic composition UNILEVER PLC (GB) 1994-03-23 EP claimed
EP-0342054-B1 Cosmetic composition UNILEVER PLC (GB) 1993-11-03 EP claimed
EP-0342056-A2 Cosmetic composition UNILEVER PLC (GB) 1989-11-15 EP claimed
EP-0342055-A2 Use of pyroglutamic acid alkyl esters for the manufacture of a medicament for the treatment of ichthyosis UNILEVER PLC (GB) 1989-11-15 EP claimed
EP-0342054-A2 Cosmetic composition UNILEVER PLC (GB) 1989-11-15 EP claimed
EP-0176217-B1 PYROGLUTAMIC ACID ESTERS, THEIR SYNTHESIS AND USE IN TOPICAL PRODUCTS UNILEVER PLC (GB) 1989-06-07 EP claimed
US-4774255-A SKIN DISORDERS LEVER BROTHERS COMPANY (US) 1988-09-27 US claimed
EP-0277428-A2 Cosmetic composition UNILEVER PLC (GB) 1988-08-10 EP claimed
EP-2744473-A1 SKIN ENGAGING MEMBER COMPRISING AN ANTI-IRRITATION AGENT The Gillette Company (US) 2014-06-25 EP disclosed
WO-2013025857-A1 SKIN ENGAGING MEMBER COMPRISING AN ANTI-IRRITATION AGENT THE GILLETTE COMPANY (US) 2013-02-21 WO disclosed
US-20130042482-A1 Skin Engaging Member Comprising An Anti-Irritation Agent THE GILLETTE COMPANY LLC 2013-02-21 US disclosed
US-20020119174-A1 Compositions useful for regulating hair growth containing metal complexes of oxidized carbohydrates PROCTER & GAMBLE COMPANY, THE 2002-08-29 US disclosed
US-20020035070-A1 Method of regulating hair growth using metal complexes of oxidized carbohydrates THE PROCTER & GAMBLE COMPANY 2002-03-21 US disclosed
EP-0334586-A1 Carbohydrate lactam derivatives and their use in cosmetic compositions UNILEVER PLC (GB) 1989-09-27 EP disclosed
EP-0334585-A2 Cosmetic composition UNILEVER PLC (GB) 1989-09-27 EP disclosed
EP-0176217-B1 PYROGLUTAMIC ACID ESTERS, THEIR SYNTHESIS AND USE IN TOPICAL PRODUCTS UNILEVER PLC (GB) 1989-06-07 EP disclosed
US-4832946-A CELL CULTURE FOR HAIR GROWTH CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC., A CORP. OF NY 1989-05-23 US disclosed
EP-0277428-A2 Cosmetic composition UNILEVER PLC (GB) 1988-08-10 EP disclosed
EP-0272920-A1 Cosmetic composition UNILEVER PLC (GB) 1988-06-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020119174-A1 Compositions useful for regulating hair growth containing metal complexes of oxidized carbohydrates OSTC, LPO, UGCG LMNA 3933/4885CNR1 3357/4885DAGLA 1160/4885
US-20130042482-A1 Skin Engaging Member Comprising An Anti-Irritation Agent CUTA, ITCH, DSG1 LMNA 3331/4885CNR1 2269/4885DAGLA 90/4885
US-20020035070-A1 Method of regulating hair growth using metal complexes of oxidized carbohydrates OSTC, SOD1, OTC LMNA 4710/4885CNR1 3805/4885DAGLA 2728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.